CN1143495A - Ointment for eliminating tinea - Google Patents

Ointment for eliminating tinea Download PDF

Info

Publication number
CN1143495A
CN1143495A CN 95111936 CN95111936A CN1143495A CN 1143495 A CN1143495 A CN 1143495A CN 95111936 CN95111936 CN 95111936 CN 95111936 A CN95111936 A CN 95111936A CN 1143495 A CN1143495 A CN 1143495A
Authority
CN
China
Prior art keywords
ointment
tinea
medicine
norfloxacin
dexamethasone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 95111936
Other languages
Chinese (zh)
Other versions
CN1062128C (en
Inventor
王阶平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95111936A priority Critical patent/CN1062128C/en
Publication of CN1143495A publication Critical patent/CN1143495A/en
Application granted granted Critical
Publication of CN1062128C publication Critical patent/CN1062128C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An ointment for curing tinea corporis, favus of the scalp, tinea manuum, tinea pedis and onychomycosis contains clotrimazole, griseofulvin, phenergan, dexamethasone, chlorpheniramine, norfloxacin, and white vaseline and features short course of treatment (4-5 weeks), high effective rate (100%) and cure rate (more than 95%) and no recurrence.

Description

Ointment for eliminating tinea
The present invention relates to the tinea ointment of a kind of treatment and removal body, head, hands, foot, tinea unguium.
The tinea cream of present known treatment body, head, hands, foot, tinea unguium has multiple, as: JIAOXIAN YICIJING, miconazole, Ge Hong beriberi liquor, clotrimazole tinea liquid etc., therapeutic effect is undesirable, and the course of treatment is long, serious symptom can not be effected a radical cure, and particularly this class stubborn dermatitis disease of weevil tinea more is difficult to cure; The medicine that has is big to skin irritation, and relapse rate is higher, as the Ge Hong beriberi liquor, till settled the present, does not also have a kind of ideal medicament that can effect a radical cure above-mentioned tinea class.
The purpose of this invention is to provide and a kind ofly can fast and effeciently effect a radical cure the medicine of body, head, hands, foot, tinea unguium, control no longer recurrence behind Yu simultaneously, without any side effects to human body.
The present invention utilizes known western proprietary assembly to make, and it is made up of following medicine components: (every hectogram ointment contains the medicine component)
Clotrimazole 1~3g
Griseofulvin 1~3g
Promethazine 0.1~0.5g
Dexamethasone 0.006~0.015g
Chlorphenamine 0.02~0.05g
Norfloxacin 0.5~2g
Surplus is medical petrolatum oil (being added to 100g)
The medicine grinding of above-mentioned amount is made ointment with the vaseline oil mixing, and the coating affected part gets final product.
The present invention compares with existing similar medicine has following advantage:
1, short treating period, cure rapidly, general tinea corporis or patient with slight symptoms's 1~2 week recovery from illness, ringworm 4~5 week recovery from illness that serious symptom or tinea unguium class refractory are healed: safety non-toxic, nonirritant, can suppress tinea bacteria growing, antipruritic, antiinflammatory, good analgesic effect quickly and effectively, promote the histiocyte regeneration function, dermatophytes is had extremely strong killing action, and effective percentage be 100%, cure rate is more than 95, no longer recurrence after the healing:
2, preparation is easy, easy to use, and formulation rate is few, and significant curative effect is promptly arranged in a short time.
Below in conjunction with specific embodiment the present invention is made a detailed description.
Embodiment 1:
Get 5 of clotrimazole sheets, every contains clotrimazole 0.2g; 5 of griseofulvin tablets, every contains griseofulvin 0.2g; 8 of promethazines, every contains promethazine 0.025g; 16 of dexamethasone, every contains 0.75 milligram of dexamethasone; 8 of chlorphenamines, every contains 5 milligrams of chlorphenamines; Norfloxacin glue is assisted 10, and every contains norfloxacin 0.1g; 6 kinds of medicines are ground to form 120~200 order fine powders and Bai Fanlin oil 96.748g mixing make ointment, the coating affected part gets final product.
Embodiment 2:
Get clotrimazole 2g, griseofulvin 2g, promethazine 0.4g, dexamethasone 0.015g, chlorphenamine 0.04g, norfloxacin 1g grinds to form 120~200 order fine powders with 6 kinds of medicines and white vaseline oil 94.545g mixing is made unguentum, spreads on the affected part and gets final product.

Claims (1)

1, a kind of ointment for the treatment of body, head, brothers, tinea unguium is characterized in that it is made up of following medicine components: (every hectogram ointment contains the medicine component)
Clotrimazole 1~3g
Griseofulvin 1~3g
Promethazine 0.1~0.5g
Dexamethasone 0.006~0.015g
Chlorphenamine 0.02~0.05g
Norfloxacin 0.5~2g
Surplus is medical petrolatum oil (being added to 100g)
Above-mentioned amount medicine grinding is hybridly prepared into ointment with medical petrolatum oil.
CN95111936A 1995-08-18 1995-08-18 Ointment for eliminating tinea Expired - Fee Related CN1062128C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95111936A CN1062128C (en) 1995-08-18 1995-08-18 Ointment for eliminating tinea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95111936A CN1062128C (en) 1995-08-18 1995-08-18 Ointment for eliminating tinea

Publications (2)

Publication Number Publication Date
CN1143495A true CN1143495A (en) 1997-02-26
CN1062128C CN1062128C (en) 2001-02-21

Family

ID=5079169

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95111936A Expired - Fee Related CN1062128C (en) 1995-08-18 1995-08-18 Ointment for eliminating tinea

Country Status (1)

Country Link
CN (1) CN1062128C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348202C (en) * 2005-04-28 2007-11-14 刘朝雄 Oral compound preparation for treating skin disease
CN106580929A (en) * 2016-12-02 2017-04-26 贺敏 Skin disease medicine composition, preparation method and application thereof
CN110354134A (en) * 2019-08-29 2019-10-22 周德文 A kind of ointment and preparation method thereof for treating chronic inflammation anaphylaxis dermatosis
CN110559259A (en) * 2019-09-23 2019-12-13 郭小兵 plaster for treating intractable skin diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1019929C (en) * 1990-03-21 1993-02-24 朱晏 Preparation method of norfloxacin beriberi water
CN1021798C (en) * 1990-12-19 1993-08-18 大连市医药科学研究所 Preparation process of tinea-removing film coating agent

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348202C (en) * 2005-04-28 2007-11-14 刘朝雄 Oral compound preparation for treating skin disease
CN106580929A (en) * 2016-12-02 2017-04-26 贺敏 Skin disease medicine composition, preparation method and application thereof
CN110354134A (en) * 2019-08-29 2019-10-22 周德文 A kind of ointment and preparation method thereof for treating chronic inflammation anaphylaxis dermatosis
CN110559259A (en) * 2019-09-23 2019-12-13 郭小兵 plaster for treating intractable skin diseases

Also Published As

Publication number Publication date
CN1062128C (en) 2001-02-21

Similar Documents

Publication Publication Date Title
CN109646712B (en) Colloidal sulfur liquid dressing and preparation method thereof
US20220183951A1 (en) Skin treatment methods and compositions with retinoid and delivery systems thereof
Samarh et al. Evidence based medical use of aloe vera extracts, short review of literature
CN101612278B (en) Medicine for external application for treating pyogenic type contaminated wounds
CN1062128C (en) Ointment for eliminating tinea
EP2260853A3 (en) Biocompatible polymers for a medical composition
JP2798287B2 (en) Anti-inflammatory agent
CN1224406C (en) Medical ointment Jiaoxuanxiao for treating beriberi
CN102526494B (en) Ointment for treating burning
CN1911231A (en) Medicine for treating burns
CN1093923A (en) Wound, ulcer loose
CN107929098A (en) A kind of cosmetics and skincare product and the pharmaceutical composition for treating burn and scald
CN1057467C (en) Medicine for treating impetigo
CN115844784B (en) Composition for relieving inflammation of dry skin and application and preparation method thereof
CN1105561C (en) Medicine for treating bromhidrosis and beriberi
CN1247204C (en) Medicine for treating beri-beri
JPH1160494A (en) Preparation for preventing recurrence of atopic dermatitis
CN1086125C (en) Externally used medicine for treating tinea
CN1706381A (en) Frostbite and chilblain treating ointment
Fabrizi et al. Calcipotriol and psoriasis in children
CN1056987C (en) Medicine for curing viral warts
CN112121062A (en) External-use medicine composition for treating bromhidrosis
CN1245071A (en) Medicine for treating cervical erosion
CN115054614A (en) Facial cleansing cream for radically treating facial acne and preparation method thereof
CN116059239A (en) Composition containing cannabidiol and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee